SARAJEVO (Bosnia and Herzegovina), December 19 (SeeNews) â Luxembourg-based Haden SA has sold part of its holdings in Bosnian drug maker Bosnalijek [SAJ:BSNLR] for 17 million marka ($9.7 million/8.7 million euro), Sarajevo Stock Exchange (SASE) data showed.